Semantic Segmentation: #AI for Analyzing Developmental Toxicity in #Zebrafish 🐟📉 🔬 Semantic segmentation powered by AI is a game-changer in evaluating developmental toxicity. At #ZeClinics, we use #DeepLearning models to analyze thousands of curated zebrafish images, assessing the impact of different molecules on development. 🧩 This technology allows us to accurately delineate anatomical structures and detect potential teratogenic effects, providing critical insights into drug safety and efficacy. Want to know more? Read the full article on our blog to dive into the details of our AI-driven approach. https://bit.ly/3MAU3Hw 🚀 Up next: Discover how #MachineLearning is used for drug toxicity classification in zebrafish larvae. Stay tuned!
ZeClinics
Investigación biotecnológica
Sant Feliu de Llobregat, Barcelona 7700 seguidores
ZeClinics is a Contract Research Organization (CRO) using zebrafish for drug discovery and biomedical research.
Sobre nosotros
ZeClinics is a leading zebrafish-expert CRO, dedicated to tailoring innovative solutions for understanding human disease and advancing drug and target discovery. Our mission is to accelerate research by providing deep in vivo insights, enabling reliable safety and efficacy assessments of new drugs and chemical compounds to reach the market faster. We challenge the traditional discovery process by integrating our expertise in zebrafish biology with cutting-edge lab automation and artificial intelligence. As specialists in CRISPR genome editing, ZeClinics creates custom genome-edited zebrafish models to accurately mimic human diseases. This approach allows us to evaluate the biomedical relevance of candidate compounds and genes in vivo. Our unique zebrafish platforms bridge the gap between cell cultures and mammalian models, offering faster, cost-effective investigations that emphasize proof-of-principle experiments for rapid go/no-go decision making, thereby accelerating the early-stage development of new compounds. ZeClinics offers essential services to pharmaceutical, biotech, nutraceutical, and agrochemical companies, as well as academic research institutions worldwide, helping to enhance and expedite their R&D efforts.
- Sitio web
-
http://zeclinics.com/
Enlace externo para ZeClinics
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 11 a 50 empleados
- Sede
- Sant Feliu de Llobregat, Barcelona
- Tipo
- De financiación privada
- Fundación
- 2013
- Especialidades
- Toxicology, Oncology, Drug Discovery, Zebrafish, Neurobiology, CRISPR/Cas9, Disease models, Phenotypical screening, Cardiovascular, Ophthalmology y Tol2
Productos
Ubicaciones
-
Principal
Carrer de Laureà Miró 408-410
Sant Feliu de Llobregat, Barcelona 08980, ES
Empleados en ZeClinics
-
Isabella Romer, PhD
Grants Manager 🧪 / Nanotechnology, Nanotoxicology, Environmental Science
-
Anna Navarro Cuenca
Senior Associate Scientist
-
Simone Calzolari
Chief Executive Officer at ZeClinics
-
Valentina Schiavone
Doctora en BioMedicina | Gestora de Calidad en ZeClinics | PG Cert en Calidad para Industria Farmacéutica | Innovacion y Cumplimiento Normativo |…
Actualizaciones
-
Deep Learning Applied to Zebrafish: Automated Cardiac Analysis🐟❤️ 🧠 Deep learning is revolutionizing how we study cardiac health in zebrafish. Our tool, ZeCardioAI, automates the analysis of zebrafish larvae heart videos, providing precise measurements of heart parameters such as rhythm and contractility (see the video below). 🔍 With ZeCardioAI, we’re able to detect subtle changes in heart function and assess drug effects with unprecedented accuracy. This automation not only speeds up the process but also eliminates human bias, enhancing the reliability of our findings. Curious about how ZeCardioAI is changing the game in cardiac research? Explore the full article on our blog to learn more about this innovative tool and its impact on drug discovery. https://bit.ly/3MAU3Hw 🚀 Next: Learn how semantic segmentation with AI is being used to assess #DevelopmentalToxicity in #zebrafish. Stay tuned!
-
🔬 Drug discovery is evolving faster than ever, but the process still faces significant bottlenecks. At #ZeClinics, we're tackling these challenges head-on by leveraging #datascience and #AI to accelerate #drugdevelopment and uncover new therapeutic possibilities. 🧬 🔍 Discover how we're automating phenotyping with #deeplearning in our #ZeCardioAI tool, delivering rapid cardiac analyses that can reshape cardiovascular #drugdiscovery in our blog: https://bit.ly/3MAU3Hw
-
ZeClinics ha compartido esto
Scientific Advisor & Account Manager. Redefining Safety and Efficacy in Preclininical Drug Discovery for Pharma & Biotech: Let's innovate together! DMs if you want to learn how.
Exciting news! 🚀 #ZeClinics will be attending the #Neuroscience2024 Conference in Chicago from October 6th-9th. You’ll find us at Booth 454. 🐟 Come discover how #zebrafish can accelerate your #drugdiscovery process, support #genetherapy development, and so much more. 💡 Curious how zebrafish models can transform your research? 🙌 Stop by and let’s talk! Looking forward to meeting you there! See you in Chicago! 👋 #Neuroscience2024 #DrugDiscovery #GeneTherapy #Zebrafish #Biotech #Innovation
-
⚠The Growing Volume & Complexity of Data Make #DataScience More Critical Than Ever! The amassing of huge datasets may allow researchers to gain fuller, more accurate pictures of complex biological systems. But here’s the big question: Do you think we are truly capturing the opportunities that massive datasets present? Share your thoughts in the comments! 👇 📈 As biomedical research continues to generate massive datasets, the challenge of transforming raw data into actionable insights becomes more critical. To overcome challenges and capture the opportunities data presents, life sciences organizations need a robust approach to #datascience. Artificial intelligence (AI) is helping researchers extract salient information from those massive datasets. The AI-influenced paradigm emphasizes speed and efficiency in data discovery, data processing, quality, and integration, and improves predictive analytics. 💡Reality check: Despite the potential, most sectors are still scratching the surface. The integration of data science and #AI will be essential in fully unlocking the insights hidden in this data. Next, we’ll explore how data science can reshape #drugdiscovery — stay tuned!
-
How much data do you think biomedical/healthcare sciences generate each year? 🌍 #DataExplotion in #LifeSciences is here! 🚀 In the last decade, the volume of data generated in biomedical and healthcare research has grown at an unprecedented rate, driven by advances in high-throughput technologies (that generate large-scale data related to disciplines of biology, like genomics), electronic health records (EHRs), medical imaging, and clinical trials. Data is the fuel that powers new discoveries. But how much data are we talking about?💡 Vote below and find out if you know the true scale of this data explosion! 📊 See the correct answer in the comments bellow.👇 Are we ready to turn this vast ocean of information into meaningful insights? Stay tuned for more on how #datascience is transforming biomedical research.
El contenido no está disponible aquí
Accede a este contenido y mucho más en la aplicación de LinkedIn
-
In biomedical research, effective #DataManagement is crucial. It drives the accuracy of discoveries, accelerates innovation, and ensures that complex biological data is used to its fullest potential. We've just published an article in our #blog that dives deep into how this field has evolved: 🔹From #RelationalDatabases 🔸Through #Networks 🔹To #KnowledgeGraphs 💡 Understanding these advancements is key to unlocking new potentials in biomedical research and drug development. We’d love to hear your thoughts: How do you think knowledge graphs will impact the future of biomedical research? Share your insights in the comments! 💬👇 If you’re passionate about biomedicine, bioinformatics, or technological innovation, this article is a must-read! 🧬💊 ➡️ Check it out here: https://bit.ly/3ynYBNW #DrugDiscovery #Bioinformatics #BiomedicalResearch #Innovation #ZeClinics
-
🌟 Insights from Claudia Miguel: A Journey of Growth at ZeClinics We're excited to share a testimonial from Claudia Miguel, our Market Access Specialist. In this video, Claudia talks about her inspiring journey of growth and development within our dynamic, diverse, and supportive work environment. Discover how her experiences across various roles have enriched her career and contributed to our collective success. Watch the video to learn more about why ZeClinics is an exceptional place to work and grow professionally! 🚀👩🔬 #ZeClinics #EmployeeStories #CareerGrowth #WorkplaceCulture #TeamZeClinics
-
📣 Join Josep Carreras Leukaemia Research Institute's mission and be the next leader in #BloodCancer research 👩🔬 As an associated partner, we're thrilled to announce that the 3rd call for the #CarrerasLeaders MSCA COFUND postdoctoral program is now open, and invites 6⃣ exceptional #PostdoctoralResearchers to participate in a transformative 3-year journey at the Josep Carreras Institute 🚀! 🎓 🗓️ Application deadline: October 27, 2024 Find out more👇 https://lnkd.in/dP7ccE8C
-
🚀 Unlock Affordable Zebrafish Genetic Modeling with Our STARTER PACKAGES! 🧬 In our latest newsletter edition, we introduce the STARTER PACKAGE for zebrafish genetic modeling. Say goodbye to budget constraints and accelerate your research with: 💰 Cost-Effective Solutions: Perfect for projects with budget limitations. ⏱️ Quick Turnaround: Achieve results in just 7 weeks. 🔍 Essential Features: All the fundamental steps for creating zebrafish genetic models included. 🧪 Reduced Experimental Burden: Focus on your core research while we handle the complex processes. Plus, dive into our blog to explore related articles on CRISPR and transgenic techniques, keeping you ahead in your research. Read our full newsletter and discover more about our services and insights. #Zebrafish #GeneticEngineering #CRISPR #Transgenesis #Knockout #CRISPR/Cas9 #ZeClinics